NPCE
NeuroPace Inc
Key Financials
Revenue
$100.0M
↑ 25.1%
Net Income
$-21465000
↑ 20.9%
Operating Income
$-16338000
↑ 24.6%
EPS (Diluted)
$-0.66
↑ 29.0%
Gross Profit
$77.2M
↑ 30.7%
Total Assets
$105.6M
↑ 11.5%
Total Liabilities
$86.5M
↓ 0.1%
Cash & Equivalents
$21.7M
↑ 61.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/25/2026 | View on SEC |
| 4 | 9/21/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| SCHEDULE 13G/A | 9/4/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 8-K | 7/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NPCE |
| Company Name | NeuroPace Inc |
| CIK | 1528287 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502372700 |